Filing Details

Accession Number:
0001209191-21-027685
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-20 19:56:22
Reporting Period:
2021-04-19
Accepted Time:
2021-04-20 19:56:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1649989 Outlook Therapeutics Inc. OTLK Biological Products, (No Disgnostic Substances) (2836) 383982704
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1718004 Munther Yezan Haddadin C/O Outlook Therapeutics, Inc.
4260 Us Route 1
Monmouth Junction NJ 08852
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-04-19 10,000 $1.82 20,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct